Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?
Annals of Internal Medicine · 2025-07 · 178 (7) · 1031-1032
DOI: 10.7326/annals-24-03950 ↗Kurz gefasst
Editorial in der Zeitschrift Annals of Internal Medicine, 2025-07. Verfasst von Anjali P Kakkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana (A.P.K., T.H.L.J.). Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana (A.P.K., T.H.L.J.).
- Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana (E.R.).
ORCID-Profile: Thierry H Le Jemtel
Zitieren
APA
Kakkar, A. P., Ravussin, E., & Le Jemtel, T. H. (2025). Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?. Annals of Internal Medicine, 178(7), 1031-1032. https://doi.org/10.7326/annals-24-03950
Vancouver
Kakkar AP, Ravussin E, Le Jemtel TH. Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?. Annals of Internal Medicine. 2025;178(7):1031-1032. doi:10.7326/annals-24-03950
BibTeX
@article{Kakkar2025,
author = {Kakkar, Anjali P and Ravussin, Eric and Le Jemtel, Thierry H},
title = {Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?},
journal = {Annals of Internal Medicine},
year = {2025},
volume = {178},
number = {7},
pages = {1031--1032},
doi = {10.7326/annals-24-03950}
}
EUVIMED